Are there gender differences in outcomes after the cox-maze procedure for atrial fibrillation?

Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery

Volumn 8, Issue 3, 2013, Pages 190-198

  Henry, Linda ^a   Hunt, Sharon ^a   Holmes, Sari D ^a   Martin, Lisa M ^a   Ad, Niv ^a  

^a INOVA HEART AND VASCULAR INSTITUTE   (United States)

Author keywords

Gender; Longitudinal follow up; Outcomes; Surgical ablation

Indexed keywords

ADULT; AGED; ARTICLE; CONGESTIVE HEART FAILURE; ELECTROCARDIOGRAM; EUROSCORE; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; PROCEDURES; QUALITY OF LIFE; SEX DIFFERENCE; SHORT FORM 12; SINUS RHYTHM; SURGICAL RISK;

ADULT; ATRIAL FIBRILLATION; ELECTROCARDIOGRAPHY; FEMALE; HEART ATRIA; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; SEX FACTORS; TREATMENT OUTCOME;

EID: 84883645073     PISSN: 15569845     EISSN: 15590879     Source Type: Journal    
DOI: 10.1097/IMI.0b013e3182a2306c     Document Type: Article

References (56)

1. Go AS, Hylek EM, Phillips KA, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the An Ticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA. 2001;285:2370-2375. (Pubitemid 32424106)
2. Chugh SS, Blackshear JL, Shen WK, Hammill SC, Gersh BJ. Epidemiology and natural history of atrial fibrillation: clinical implications. J Am Coll Cardiol. 2001;37:371-378.
3. Lloyd-Jones DM, Wang TJ, Leip EP, et al. Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Circulation. 2004;110: 1042-1046. (Pubitemid 39319000)
4. Alonso A, Agarwal SK, Soliman EZ, et al. Incidence of atrial fibrillation in whites and African-Americans: the Atherosclerosis Risk in Communities (ARIC) Study. Am Heart J. 2009;158:111-117.
5. Prineas RJ, Soliman EZ, Howard G, et al. The sensitivity of the method used to detect atrial fibrillation in population studies affects group-specific prevalence estimates: ethnic and regional distribution of atrial fibrillation in the REGARDS study [published online ahead of print June 27, 2009]. J Epidemiol. 2009;19:177-181.
6. Volgman AS, Manankil MF, Mookherjee D, Trohman RG. Women with atrial fibrillation: greater risk, less attention. Gend Med. 2009;6:419-432.
7. Wyse DG, Waldo AL, DiMarco JP, et al., for the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med. 2002;347:1825-1833.
8. Van Gelder IC, Hagens VE, Bosker HA, et al., for the Rate Control versus Electrical Cardioversion for Persistent Atrial Fibrillation Study Group. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med. 2002;347:1834-1840. (Pubitemid 35417774)
9. Rienstra M, Van Veldhuisen DJ, Hagens VE, et al., for the RACE Investigators. Gender-related differences in rhythm control treatment in persistent atrial fibrillation: data of the Rate Control Versus Electrical Cardioversion (RACE) study. J Am Coll Cardiol. 2005;46:1298-1306. (Pubitemid 41615553)
10. Michelena HI, Powell BD, Brady PA, Friedman PA, Ezekowitz MD. Gender in atrial fibrillation: ten years later. Gend Med. 2010;7:206-217.
11. Santangeli P, di Biase L, Pelargonio G, Natale A. Outcome of invasive electrophysiological procedures and gender: are males and females the same? J Cardiovasc Electrophysiol. 2011;22:605-612.
12. Simon HU, Sinha AM, Horack M, et al. Abstract 12585: gender and left atrial ablation for atrial fibrillation: outcome data from the German Ablation Registry. Circulation. 2010;122:A12585.
13. Cox JL, Schuessler RB, D'Agostino HJ Jr, et al. The surgical treatment of atrial fibrillation. III. Development of a definitive surgical procedure. J Thorac Cardiovasc Surg. 1991;101:569-583.
14. Cox JL, Ad N. New surgical and catheter-based modifications of the Maze procedure. Semin Thorac Cardiovasc Surg. 2000;12:68-73.
15. Weimar T, Bailey MS, Watanabe Y, et al. The Cox-maze IV procedure for lone atrial fibrillation: a single center experience in 100 consecutive patients. J Interv Card Electrophysiol. 2011;31:47-54.
16. Hunt S, Henry L, Ad N. Using multiple databases to produce comprehensive follow-up in an effort to enhance evaluation of outcome measurements: surgical ablation (Maze) exemplar [published online ahead of print January 19, 2011]. J Healthc Qual. 2011;33:50-63.
17. Ad N, Henry L, Hunt S, Stone L. The implementation of a comprehensive clinical protocol improves long-term success after surgical treatment of atrial fibrillation. J Thorac Cardiovasc Surg. 2010;139:1146-1152.
18. Ware J, Kosinski M, Turner-Bowker D, et al. How to Score Version 2 of the SF-12 Health Survey. Lincoln, RI: Quality Metric Inc; 2002.
19. Jenkins LS. Test-Specifications for the Bubien and Kay (Revised Jenkins) Symptom Checklist: Frequency and Severity. Baltimore, MD: University of Maryland Press; 1993.
20. Bubien RS, Knotts-Dolson SM, Plumb VJ, Kay GN. Effect of radiofrequency catheter ablation on health-related quality of life and activities of daily living in patients with recurrent arrhythmias. Circulation. 1996;94: 1585-1591. (Pubitemid 26320262)
21. Jenkins LS, Brodsky M, Schron E, et al. Quality of life in atrial fibrillation: the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. Am Heart J. 2005;149:112-120.
22. Dorian P, Jung W, Newman D, et al. The impairment of health-related quality of life in patients with intermittent atrial fibrillation: implications for the assessment of investigational therapy. J Am Coll Cardiol. 2000;36: 1303-1309.
23. Data analysis of The Society of Thoracic Surgeons National Adult Cardiac Surgery Database. 2007. Available at: http://www.sts.org/qualityresearch- patient-safety/quality. Accessed February 24, 2013.
24. Calkins H, Brugada J, Packer DL, et al., for the Heart Rhythm Society; European Heart Rhythm Association; European Cardiac Arrhythmia Society; American College of Cardiology; American Heart Association; The Society of Thoracic Surgeons. HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation developed in partnership with the European Heart Rhythm Association (EHRA) and the European Cardiac Arrhythmia Society (ECAS); in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), and The Society of Thoracic Surgeons (STS). Endorsed and approved by the governing bodies of the American College of Cardiology, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, The Society of Thoracic Surgeons, and the Heart Rhythm Society. Europace. 2007;9:335-379.
25. Ad N, Henry L, Hunt S, Barnett S, Stone L. The Cox-Maze III procedure success rate: comparison by electrocardiogram, 24-hour holter monitoring and long-term monitoring. Ann Thorac Surg. 2009;88:101-105.
26. Henry L, Ad N. Long-term monitoring for patients after surgical ablation of atrial fibrillation: are all devices the same? Innovations (Phila). 2010;5:259-264.
27. Wolbrette DL. Risk of proarrhythmia with class III antiarrhythmic agents: sex-based differences and other issues. Am J Cardiol. 2003;91:39DY44D.
28. American Heart Association. Heart disease and stroke statisticsV2011 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Available at: http://www.heart.org/HEARTORG/. Accessed February 24, 2013.
29. Kerr CR, Humphries K. Gender-related differences in atrial fibrillation. J Am Coll Cardiol. 2005;46:1307-1308. (Pubitemid 41615554)
30. Paquette M, Roy D, Talajic M, et al. Role of gender and personality on quality-of-life impairment in intermittent atrial fibrillation. Am J Cardiol. 2000;86:764-768.
31. Fang MC, Singer DE, Chang Y, et al. Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study. Circulation. 2005;112:1687-1691. (Pubitemid 41368143)
32. Roten L, Rimoldi SF, Schwick N, et al. Gender differences in patients referred for atrial fibrillation management to a tertiary center. Pacing Clin Electrophysiol. 2009;32:622-626.
33. Reid JM, Dai D, Gubitz GJ, Kapral MK, Christian C, Phillips SJ. Gender differences in stroke examined in a 10-year cohort of patients admitted to a Canadian teaching hospital. Stroke. 2008;39:1090-1095. (Pubitemid 351440674)
34. Friberg J, Scharling H, Gadsboll N, Truelsen T, Jensen GB, for the Copenhagen City Heart Study. Comparison of the impact of atrial fibrillation on the risk of stroke and cardiovascular death in women versus men (The Copenhagen City Heart Study). Am J Cardiol. 2004;94: 889-894. (Pubitemid 39359174)
35. Forster A, Gass A, Kern R, et al. Gender differences in acute ischemic stroke: etiology, stroke patterns and response to thrombolysis. Stroke. 2009;40:2428-2432.
36. Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on Atrial Fibrillation. Chest. 2010;137:263-272.
37. Ad N, Henry L, Schlauch K, Holmes SD, Hunt S. The CHADS score role in managing anticoagulation after surgical ablation for atrial fibrillation. Ann Thorac Surg. 2010;90:1257-1262.
38. Hammond J, Salamonson Y, Davidson P, Everett B, Andrew S. Why do women underestimate the risk of cardiac disease? A literature review. Aust Crit Care. 2007;20:53-59.
39. Perelman J, Mateus C, Fernandes A. Gender equity in treatment for cardiac heart disease in Portugal. Soc Sci Med. 2010;71:25-29.
40. Patel D, Armaganijan LV, Morillo CA. Atrial fibrillation catheter ablation in females: same hardware, different findings. Expert Rev Cardiovasc Ther. 2011;9:1391-1395.
41. Patel D, Mohanty P, Di Biase L, et al. Outcomes and complications of catheter ablation for atrial fibrillation in females. Heart Rhythm. 2010; 7:167-172.
42. Dagres N, Clague JR, Breithardt G, Borggrefe M. Significant gender-related differences in radiofrequency catheter ablation therapy. J Am Coll Cardiol. 2003;42:1103-1107. (Pubitemid 37108601)
43. Forleo GB, Tondo C, De Luca L, et al. Gender-related differences in catheter ablation of atrial fibrillation. Europace. 2007;9:613-620. (Pubitemid 47263791)
44. Spragg DD, Dalal D, Cheema A, et al. Complications of catheter ablation for atrial fibrillation: incidence and predictors. J Cardiovasc Electrophysiol. 2008;19:627-631. (Pubitemid 351832292)
45. Waller CG. Understanding prehospital delay behavior in acute myocardial infarction in women. Crit Pathw Cardiol. 2006;5:228-234. (Pubitemid 44912341)
46. Rosenfeld AG. Treatment-seeking delay among women with acute myocardial infarction: decision trajectories and their predictors. Nurs Res. 2004;53:225-236. (Pubitemid 40090963)
47. Harralson TL. Factors influencing delay in seeking treatment for acute ischemic symptoms among lower income, urban women. Heart Lung. 2007;36:96-104. (Pubitemid 46386283)
48. Kaul P, Chang WC, Westerhout CM, Graham MM, Armstrong PW. Differences in admission rates and outcomes between men and women presenting to emergency departments with coronary syndromes. CMAJ. 2007;177:1193-1199. (Pubitemid 350178608)
49. Canto JG, Rogers WJ, Goldberg RJ, et al., for the NRMI Investigators. Association of age and sex with myocardial infarction symptom presentation and in-hospital mortality. JAMA. 2012;307:813-822.
50. Conen D, Tedrow UB, Koplan BA, Glynn RJ, Buring JE, Albert CM. Influence of systolic and diastolic blood pressure on the risk of incident atrial fibrillation in women. Circulation. 2009;119:2146-2152.
51. Conen D, Ridker PM, Everett BM, et al. A multimarker approach to assess the influence of inflammation on the incidence of atrial fibrillation in women [published online ahead of print May 25, 2010]. Eur Heart J. 2010;31:1730-1736.
52. Aguado-Romeo MJ, Màrquez-Calderón S, Buzón-Barrera ML, for the Medical Practice Variations Andalusian Group. Hospital mortality in acute coronary syndrome: differences related to gender and use of percutaneous coronary procedures. BMC Health Serv Res. 2007;7:110.
53. Miyasaka Y, Barnes ME, Gersh BJ, et al. Coronary ischemic events after first atrial fibrillation: risk and survival. Am J Med. 2007;120:357-363.
54. Barnett SD, Ad N. Surgical ablation as treatment for the elimination of atrial fibrillation: a meta-analysis. J Thorac Cardiovasc Surg. 2006; 131:1029-1035.
55. Ad N. How do we spell maze? A dialogue concerning definitions and goals. J Thorac Cardiovasc Surg. 2006;132:1253-1255.
56. Ad N. The challenge of defining procedural endpoints for the surgical treatment of atrial fibrillation. Eur J Cardiothorac Surg. 2012;41:119-120.